Hypothalamic Dysfunction and Multiple Sclerosis: Implications for Fatigue and Weight Dysregulation

Kevin G. Burfeind, Vijayshree Yadav, Daniel Marks

Research output: Contribution to journalReview article

11 Citations (Scopus)

Abstract

Signs and symptoms of multiple sclerosis are usually attributed to demyelinating lesions in the spinal cord or cerebral cortex. The hypothalamus is a region that is often overlooked yet controls many important homeostatic functions, including those that are perturbed in multiple sclerosis. In this review we discuss how hypothalamic dysfunction may contribute to signs and symptoms in people with multiple sclerosis. While dysfunction of the hypothalamic-pituitary-adrenal axis is common in multiple sclerosis, the effects and mechanisms of this dysfunction are not well understood. We discuss three hypothalamic mechanisms of fatigue in multiple sclerosis: (1) general hypothalamic-pituitary-adrenal axis hyperactivity, (2) disordered orexin neurotransmission, (3) abnormal cortisol secretion. We then review potential mechanisms of weight dysregulation caused by hypothalamic dysfunction. Lastly, we propose future studies and therapeutics to better understand and treat hypothalamic dysfunction in multiple sclerosis. Hypothalamic dysfunction appears to be common in multiple sclerosis, yet current studies are underpowered and contradictory. Future studies should contain larger sample sizes and standardize hormone and neuropeptide measurements.

Original languageEnglish (US)
Article number98
JournalCurrent Neurology and Neuroscience Reports
Volume16
Issue number11
DOIs
StatePublished - Nov 1 2016

Fingerprint

Multiple Sclerosis
Fatigue
Weights and Measures
Signs and Symptoms
Neuropeptides
Synaptic Transmission
Cerebral Cortex
Sample Size
Hypothalamus
Hydrocortisone
Spinal Cord
Hormones

Keywords

  • Fatigue
  • Hypothalamus
  • Multiple sclerosis
  • Neuroendocrinology
  • Weight dysregulation

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology

Cite this

Hypothalamic Dysfunction and Multiple Sclerosis : Implications for Fatigue and Weight Dysregulation. / Burfeind, Kevin G.; Yadav, Vijayshree; Marks, Daniel.

In: Current Neurology and Neuroscience Reports, Vol. 16, No. 11, 98, 01.11.2016.

Research output: Contribution to journalReview article

@article{097216abab5240ee93f7175e32c28a3f,
title = "Hypothalamic Dysfunction and Multiple Sclerosis: Implications for Fatigue and Weight Dysregulation",
abstract = "Signs and symptoms of multiple sclerosis are usually attributed to demyelinating lesions in the spinal cord or cerebral cortex. The hypothalamus is a region that is often overlooked yet controls many important homeostatic functions, including those that are perturbed in multiple sclerosis. In this review we discuss how hypothalamic dysfunction may contribute to signs and symptoms in people with multiple sclerosis. While dysfunction of the hypothalamic-pituitary-adrenal axis is common in multiple sclerosis, the effects and mechanisms of this dysfunction are not well understood. We discuss three hypothalamic mechanisms of fatigue in multiple sclerosis: (1) general hypothalamic-pituitary-adrenal axis hyperactivity, (2) disordered orexin neurotransmission, (3) abnormal cortisol secretion. We then review potential mechanisms of weight dysregulation caused by hypothalamic dysfunction. Lastly, we propose future studies and therapeutics to better understand and treat hypothalamic dysfunction in multiple sclerosis. Hypothalamic dysfunction appears to be common in multiple sclerosis, yet current studies are underpowered and contradictory. Future studies should contain larger sample sizes and standardize hormone and neuropeptide measurements.",
keywords = "Fatigue, Hypothalamus, Multiple sclerosis, Neuroendocrinology, Weight dysregulation",
author = "Burfeind, {Kevin G.} and Vijayshree Yadav and Daniel Marks",
year = "2016",
month = "11",
day = "1",
doi = "10.1007/s11910-016-0700-3",
language = "English (US)",
volume = "16",
journal = "Current Neurology and Neuroscience Reports",
issn = "1528-4042",
publisher = "Current Medicine Group",
number = "11",

}

TY - JOUR

T1 - Hypothalamic Dysfunction and Multiple Sclerosis

T2 - Implications for Fatigue and Weight Dysregulation

AU - Burfeind, Kevin G.

AU - Yadav, Vijayshree

AU - Marks, Daniel

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Signs and symptoms of multiple sclerosis are usually attributed to demyelinating lesions in the spinal cord or cerebral cortex. The hypothalamus is a region that is often overlooked yet controls many important homeostatic functions, including those that are perturbed in multiple sclerosis. In this review we discuss how hypothalamic dysfunction may contribute to signs and symptoms in people with multiple sclerosis. While dysfunction of the hypothalamic-pituitary-adrenal axis is common in multiple sclerosis, the effects and mechanisms of this dysfunction are not well understood. We discuss three hypothalamic mechanisms of fatigue in multiple sclerosis: (1) general hypothalamic-pituitary-adrenal axis hyperactivity, (2) disordered orexin neurotransmission, (3) abnormal cortisol secretion. We then review potential mechanisms of weight dysregulation caused by hypothalamic dysfunction. Lastly, we propose future studies and therapeutics to better understand and treat hypothalamic dysfunction in multiple sclerosis. Hypothalamic dysfunction appears to be common in multiple sclerosis, yet current studies are underpowered and contradictory. Future studies should contain larger sample sizes and standardize hormone and neuropeptide measurements.

AB - Signs and symptoms of multiple sclerosis are usually attributed to demyelinating lesions in the spinal cord or cerebral cortex. The hypothalamus is a region that is often overlooked yet controls many important homeostatic functions, including those that are perturbed in multiple sclerosis. In this review we discuss how hypothalamic dysfunction may contribute to signs and symptoms in people with multiple sclerosis. While dysfunction of the hypothalamic-pituitary-adrenal axis is common in multiple sclerosis, the effects and mechanisms of this dysfunction are not well understood. We discuss three hypothalamic mechanisms of fatigue in multiple sclerosis: (1) general hypothalamic-pituitary-adrenal axis hyperactivity, (2) disordered orexin neurotransmission, (3) abnormal cortisol secretion. We then review potential mechanisms of weight dysregulation caused by hypothalamic dysfunction. Lastly, we propose future studies and therapeutics to better understand and treat hypothalamic dysfunction in multiple sclerosis. Hypothalamic dysfunction appears to be common in multiple sclerosis, yet current studies are underpowered and contradictory. Future studies should contain larger sample sizes and standardize hormone and neuropeptide measurements.

KW - Fatigue

KW - Hypothalamus

KW - Multiple sclerosis

KW - Neuroendocrinology

KW - Weight dysregulation

UR - http://www.scopus.com/inward/record.url?scp=84988603158&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988603158&partnerID=8YFLogxK

U2 - 10.1007/s11910-016-0700-3

DO - 10.1007/s11910-016-0700-3

M3 - Review article

C2 - 27662896

AN - SCOPUS:84988603158

VL - 16

JO - Current Neurology and Neuroscience Reports

JF - Current Neurology and Neuroscience Reports

SN - 1528-4042

IS - 11

M1 - 98

ER -